Trial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With Schizophrenia
Public ClinicalTrials.gov record NCT05245539. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind Trial to Study the Effect of CVL-231 on 24-Hour Ambulatory Blood Pressure in Participants With Schizophrenia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this trial is to characterize the effects of 2 oral doses (over 8 weeks total) of CVL-231 on ambulatory blood pressure and heart rate in patients with stable schizophrenia.
Study identification
- NCT ID
- NCT05245539
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Enrollment
- 151 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 30 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 24, 2022 (Actual)
- Primary completion
- Oct 19, 2022 (Actual)
- Completion
- Nov 14, 2022 (Actual)
- Last update posted
- Dec 14, 2022
2022
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pillar Clinical Research LLC | Bentonville | Arkansas | 72712 | — |
| Woodland International Research Group LLC - ERG - PPDS | Little Rock | Arkansas | 72211 | — |
| Collaborative NeuroScience Research, LLC - Torrance - Apex - PPDS | Long Beach | California | 90806 | — |
| Innovative Clinical Research, Inc - ClinEdge - PPDS | Miami | Florida | 33016 | — |
| Uptown Research Institute LLC | Chicago | Illinois | 60640 | — |
| Pillar Clinical Research LLC | Lincolnwood | Illinois | 60712 | — |
| Hassman Research Institute - Apex - PPDS | Marlton | New Jersey | 08053 | — |
| Neuro-Behavioral Clinical Research, Inc. | North Canton | Ohio | 44720 | — |
| Community Clinical Research | Austin | Texas | 78754 | — |
| Pillar Clinical Research LLC | Richardson | Texas | 75080 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05245539, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 14, 2022 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT05245539 live on ClinicalTrials.gov.